Stay updated on Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.5.3 is added to the Record History, and the previous revision v3.5.2 is removed from the list.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. The change appears to modify only version metadata and does not alter study records or visible content.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history now shows Revision: v3.4.3. The previous Revision: v3.4.2 entry was removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision history shows a new Revision: v3.4.2 added and the operating-status funding notice removed.SummaryDifference0.5%

- Check99 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and the NIH Clinical Center's operating status. Updated the page version to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

Stay in the know with updates to Dapagliflozin in Preserved EF Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Preserved EF Heart Failure Clinical Trial page.